Author: digi

Resource Planning & Capacity Models for Clinical Programs: From FTE Math to Inspection-Ready Operations

October 21, 2025 digi

Resource Planning & Capacity Models for Clinical Programs: From FTE Math to Inspection-Ready Operations Building Reliable Resource Capacity Models for Clinical Development Define demand precisely and translate it into time-phased resourcing Clinical programs fail when resourcing is a guess instead of a controlled process. The remedy is disciplined resource capacity planning anchored to protocol design,…

Clinical Project Management, Resource Planning & Capacity Models

Ethics, Equity, and Informed Consent in Clinical Research — Protecting Participants and Building Public Trust

October 21, 2025October 22, 2025 digi

Ethics, Equity, and Informed Consent in Clinical Research — Protecting Participants and Building Public Trust Informed Consent in Clinical Research: Protecting Participants While Ensuring Ethical Equity Clinical research is built upon an ethical foundation that ensures human dignity, respect, and justice. Every clinical trial must protect participants’ rights, prioritize safety, and ensure that the pursuit…

Ethics, Equity & Informed Consent

Belmont & Helsinki in Practice: Turning First Principles into Inspection-Ready Research Conduct

October 21, 2025 digi

Belmont & Helsinki in Practice: Turning First Principles into Inspection-Ready Research Conduct Applying Belmont Principles and the Declaration of Helsinki to Design, Consent, and Oversight First Principles: Belmont’s Ethic and Helsinki’s Clinical Covenant Modern clinical research rests on two enduring foundations. The Belmont Report articulates three normative pillars—Respect for Persons, Beneficence, and Justice—that frame how…

Belmont Principles & Declaration of Helsinki, Ethics, Equity & Informed Consent

Quality Agreements & Statements of Work for GxP Vendor Oversight in Clinical Trials 2026

October 21, 2025 digi

Quality Agreements & Statements of Work for GxP Vendor Oversight in Clinical Trials Writing Inspection-Ready Quality Agreements and SOWs for Clinical Vendors Why Quality Agreements and SOWs Are Twin Pillars of Vendor Control In regulated clinical research, even the most capable vendor can only deliver compliant outcomes when expectations are unambiguous and enforceable. That clarity…

Quality Agreements & SOWs, Vendor Oversight & Outsourcing

Governance, SteerCos & Stakeholder Communications in Clinical Programs: A Regulatory-Grade Operating Model

October 21, 2025 digi

Governance, SteerCos & Stakeholder Communications in Clinical Programs: A Regulatory-Grade Operating Model Running Governance, SteerCos, and Stakeholder Communications the Right Way in Clinical Development Design a governance operating model that earns trust: structures, roles, charters, and decision rights High-performing sponsors treat governance as a clinical safety mechanism, not a status ritual. That mindset starts with…

Clinical Project Management, Governance, SteerCos & Stakeholder Comms

Vendor Selection & Qualification for GxP Clinical Operations: A Compliance-First Playbook 2026

October 21, 2025 digi

Vendor Selection & Qualification for GxP Clinical Operations: A Compliance-First Playbook Choosing and Qualifying Clinical Vendors the Regulator-Ready Way Why Selection and Qualification Decide Study Success For sponsors and CROs operating in the USA, UK, and EU, vendor selection and qualification are not purchasing formalities—they are core quality and risk controls. The organizations you entrust…

Vendor Oversight & Outsourcing, Vendor Selection & Qualification

Device & Combination Product Regulations: A Global Playbook for Pathways, Quality, and Clinical Evidence

October 21, 2025 digi

Device & Combination Product Regulations: A Global Playbook for Pathways, Quality, and Clinical Evidence Designing, Investigating, and Registering Devices & Drug–Device Combinations Across Major Regulators The Global Device Rulebook: How Pathways and PMOA Drive Your Plan Medical devices and drug–device combinations live in a different regulatory universe than pure pharmaceuticals, but the strategic goal is…

Device & Combination Product Regulations, Regulatory Frameworks & Global Guidelines

Understanding Clinical Trial Fundamentals — The Global Framework of Modern Research

October 20, 2025October 22, 2025 digi

Understanding Clinical Trial Fundamentals — The Global Framework of Modern Research Understanding the Fundamentals of Clinical Trials: A Comprehensive Framework for Modern Research Clinical trials are the scientific backbone of modern medicine. They transform experimental findings into evidence-based therapies through a structured and ethical process. Every approved drug, vaccine, or device has passed through this…

Clinical Trial Fundamentals

Risk Register & Issue Management in Clinical Projects: A Regulatory-Grade Operating Model

October 20, 2025 digi

Risk Register & Issue Management in Clinical Projects: A Regulatory-Grade Operating Model Building a Defensible Risk Register and Running Inspection-Proof Issue Management Establish a clear, auditable framework: definitions, taxonomy, and a clinical risk register that works Effective oversight in clinical development begins with shared definitions and an auditable structure for the clinical risk register. A…

Clinical Project Management, Risk Register & Issue Management

Make-vs-Buy Strategy & RFP Process for Clinical Development Operations 2026

October 20, 2025 digi

Make-vs-Buy Strategy & RFP Process for Clinical Development Operations Building the Right Sourcing Model and Running a Rock-Solid RFP for Clinical Operations Strategic Foundations: When to Build In-House and When to Buy High-performing sponsors in the USA, UK, and EU treat sourcing as a strategic capability, not a tactical purchase. A make-vs-buy decision frames how…

Make-vs-Buy Strategy & RFP Process, Vendor Oversight & Outsourcing